ASCRS Live: Visual and refractive outcomes of aberration-free monofocal hydrophobic toric IOLs

Ophthalmology Times© caught up with Alice Epitropoulos at the 2023 ASCRS annual meeting in San Diego. Among her presentations at the event, she shared data regarding the visual and refractive outcomes of aberration-free monofocal hydrophobic toric IOLs.

Video transcript

Editor’s note: Transcript lightly edited for clarity.

Alice Epitropoulos, MD:

Hi, I'm Alice Epitropoulos coming to you from San Diego ASCRS. I'm a cataract and refractive surgeon in Columbus, Ohio. I'm a clinical assistant professor at The Ohio State University. I am presenting my data on enVista TORIC IOL, which is an asymmetric optic with 0 spherical aberration. So by preserving the cornea's natural positive spherical aberration, we can actually give patients the best of both worlds. Good range of field and then also excellent quality of vision. Corneal astigmatism is extremely common with a third of patients coming in for cataract surgery having a diopter or more of corneal astigmatism. And if left untreated, can really adversely affect a patient's quality of uncorrected vision. It's surprising that only about 8% of all IOL procedures include a toric lens.

So again, we looked at this is a retrospective analysis, we looked at 77 consecutive eyes that underwent cataract surgery with an enVista lens. Most patients were corrected for emmetropia some were corrected from monovision, and we looked at uncorrected distance in immediate and J vision we also looked at the rotational stability of this toric lens. So we found an exceptional range of functional vision. In these patients with more than 80% being able to see 20/30 or better at distancing intermediate, and J three are better at near so again by preserving the corneas natural spherical aberration we saw a good range of vision in these patients. Additionally, the enVista toric lens is predictable, it's rotationally stable, and does a great job in correcting or eliminating corneal astigmatism.